ContractVersion Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.6 9 exhibit106.htm EXHIBIT 10.6 Exhibit 10.6 EXECUTION VERSION AGREEMENT AND CONSENT This AGREEMENT AND CONSENT (this “Agreement”) is effective as of November 7, 2018 by and among Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders of warrants to purchase such number of shares of common stock of the Company as is set forth on EXHIBIT A hereto (collectively, the “Warrant Holders”). Capitalized terms used and not otherwise defined herein shall have their respective meanings as set forth in those certain Convertible Promissory Notes in an aggregate principal amount of $37,848,750, dated as of June 13, 2018, issued by the Company (the “Notes”) pursuant to that certain Securities Purchase Agreement dated March 26, 2018, as amended on June 13, 2018, by and among the Company and the purchasers identified on Schedule A thereto (as amended, the “Purchase Agreement”). RECITALS WHEREAS, pursuant to the Purchase Agreement, the Company issued and sold to the W